Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-010750·ADAMS STREET PARTNERS LLC
Schedule 13D ownership disclosure
Corvus Pharmaceuticals Inc
Common Stock · CUSIP: 221015100
Event date: 2026-01-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adams Street Partners, LLCReported CIK 0001193586
Shares: 3,275,616.00 · Class: 3.9%
- Adams Street 2011 Direct Fund LPReported CIK 0001507788
Shares: 694,854.00 · Class: 0.8%
- Adams Street 2012 Direct Fund LPReported CIK 0001537362
Shares: 715,361.00 · Class: 0.9%
- Adams Street 2013 Direct Fund LPReported CIK 0001564720
Shares: 541,133.00 · Class: 0.6%
- Adams Street 2014 Direct Fund LPReported CIK 0001594043
Shares: 736,033.00 · Class: 0.9%
- Adams Street 2015 Direct Venture/Growth Fund LPReported CIK 0001623365
Shares: 69,864.00 · Class: 0.1%
- Adams Street 2016 Direct Venture/Growth Fund LPReported CIK 0001653592
Shares: 67,769.00 · Class: 0.1%
- Adams Street 2017 Direct Venture/Growth Fund LPReported CIK 0001685559
Shares: 87,668.00 · Class: 0.1%
- Adams Street 2018 Direct Venture/Growth Fund LPReported CIK 0001720383
Shares: 126,806.00 · Class: 0.2%
- Adams Street Venture/Growth Fund VI LPReported CIK 0001623687
Shares: 236,128.00 · Class: 0.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-010750
- Form type
- SCHEDULE 13D/A
- Filer
- ADAMS STREET PARTNERS LLC
- CIK
- CIK 1193586
- Filed
- Feb 05, 2026
- Reporting period
- Jan 23, 2026
- Description
- Schedule 13D beneficial ownership